title: Clozapine-induced neuroleptic malignant syndrome: an interaction between dopaminergic and purinergic systems?
authors.forename: D R
authors.initials: DR
authors.lastname: Lara
authors.forename: A L
authors.initials: AL
authors.lastname: Wolf
authors.forename: M I
authors.initials: MI
authors.lastname: Lobato
authors.forename: G
authors.initials: G
authors.lastname: Baroni
authors.forename: F
authors.initials: F
authors.lastname: Kapczinski
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D065127:Dopamine D2 Receptor Antagonists; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000503:physiopathology*; D011983:Receptors, Purinergic / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D011983:Receptors, Purinergic; D003024:Clozapine